Manifold

Manifold provides AI clinical research platforms that help streamline research operations, manage data, and generate insights. The platforms help researchers across several stages of clinical study, including managing cohorts, curation of clinical and multi-omic data, data analytics, and collaboration functions for interactions with internal and external collaborators.

Manifold’s platforms include 1) Observational Study and 2) Biobank Core. Observational Study helps researchers with transforming legacy systems into digital workflows, connecting data silos, automating analytics, and collaborating securely with other stakeholders. Biobank Core helps to connect biospecimen data with clinical and genetic data for analysis, respond to questions from cohorts, and make data available for researchers.

Both platforms use AI to automate and refine data analytics processes, making it easier for researchers to generate insights.

Key customers and partnerships

As of April 2024, the company had partnered with institutions such as the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, as well as the Winship Cancer Institute of Emory University.

Funding and financials

In April 2024, Manifold raised USD 15 million in a Series A funding round led by TQ Ventures, along with participation from other venture capital firms and individual investors. The funds were set aside to further the company’s market reach and to invest in research and development initiatives to further its platform’s use cases.